Bioatla Inc (BCAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
Operating Expenses | 21,972 | 24,457 | 28,536 | 35,020 | 37,201 |
Operating Income | -21,972 | -24,457 | -28,536 | -35,020 | -37,201 |
Other Income | 900 | 1,223 | 1,611 | 1,695 | 1,449 |
Pre-tax Income | -21,072 | -23,234 | -26,925 | -33,325 | -35,752 |
Net Income Continuous | -21,072 | -23,234 | -26,925 | -33,325 | -35,752 |
Net Income | $-21,072 | $-23,234 | $-26,925 | $-33,325 | $-35,752 |
EPS Basic Total Ops | -0.44 | -0.48 | -0.55 | -0.70 | -0.75 |
EPS Basic Continuous Ops | -0.44 | -0.48 | -0.56 | -0.70 | -0.75 |
EPS Diluted Total Ops | -0.44 | -0.48 | -0.55 | -0.70 | -0.75 |
EPS Diluted Continuous Ops | -0.44 | -0.48 | -0.56 | -0.70 | -0.75 |
EPS Diluted Before Non-Recurring Items | -0.44 | -0.48 | -0.56 | -0.70 | -0.75 |
EBITDA(a) | $-21,743 | $-24,217 | $-28,168 | $-34,750 | $-36,911 |